GENEVA, June 4 -- PRIME MEDICINE, INC. (60 First StreetCambridge, Massachusetts 02141) filed a patent application (PCT/US2024/056877) for "CHEMICAL MODIFICATIONS IN PEgRNA and ngRNAs" on Nov 21, 2024. With publication no. WO/2025/111452, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KANDIMALLA, Ekambareswara Rao (c/o Prime Medicine, Inc.60 First StreetCambridge, Massachusetts 02141), PUTTA, Mallikarjuna (c/o Prime Medicine, Inc.60 First StreetCambridge, Massachusetts 02141), ALEXANDER, Seth (c/o Prime Medicine, Inc.60 F...